Skip to main content
Julia Beaver, MD, Oncology, Baltimore, MD

Julia Ann Beaver MD

Oncology•Baltimore, MD

Assistant Professor of Oncology

Join to View Full Profile

  • The Johns Hopkins Hospital600 North Wolfe StreetBaltimore, MD 21287

  • Phone+1 410-955-5000

Are you Dr. Beaver?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
Claim this profileNot you? Find your profile

Summary

  • Dr. Julia Beaver, MD is an oncologist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland and District of Columbia.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2010 - 2013
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2007 - 2010
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2007

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2010 - 2026
  • DC State Medical License
    DC State Medical License 2013 - 2024
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • Targeted Oncology - FDA Cracks down on Dangling Accelerated Approvals in 2021, Pathway Is Scrutinized
    Targeted Oncology - FDA Cracks down on Dangling Accelerated Approvals in 2021, Pathway Is ScrutinizedDecember 20th, 2021
  • FDA Posts New Websites on Accelerated Approvals for Cancer Drugs
    FDA Posts New Websites on Accelerated Approvals for Cancer DrugsOctober 29th, 2021
  • The FDA’s Accelerated Approval Process: When Drugs Are Cleared for Sale Based on Limited Evidence
    The FDA’s Accelerated Approval Process: When Drugs Are Cleared for Sale Based on Limited EvidenceOctober 18th, 2021
  • Join now to see all

Dr. Julia Beaver, Dr. Julia Beaver, MD, Dr. J Beaver, Dr. Julia Ann Beaver